Brainstorm Cell Therapeutics, Inc. (BCLI)
0.75
+0.03
(+4.02%)
USD |
OTCM |
May 29, 16:00
Brainstorm Cell Therapeutics Total Liabilities (Quarterly) : 11.76M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| NovelStem International Corp. | 2.048M |
| Summit Therapeutics, Inc. | 101.92M |
| Kezar Life Sciences, Inc. | 2.762M |
| Protara Therapeutics, Inc. | 10.72M |
| Clene, Inc. | 40.47M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 0.755M |
| Shareholders Equity (Quarterly) | -11.01M |
| Debt to Equity Ratio | -0.1352 |
| Current Ratio | 0.0156 |
| Net Debt Paydown Yield | -0.89% |